Vol 7: Pharmacokinetics of fluralaner in dogs following a single oral or intravenous administration.Reportar como inadecuado



 Vol 7: Pharmacokinetics of fluralaner in dogs following a single oral or intravenous administration.


Vol 7: Pharmacokinetics of fluralaner in dogs following a single oral or intravenous administration. - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

Descargar gratis o leer online en formato PDF el libro: Vol 7: Pharmacokinetics of fluralaner in dogs following a single oral or intravenous administration.
This article is from Parasites & Vectors, volume 7.AbstractBackground: Fluralaner is a novel systemic insecticide and acaricide. The purpose of these studies was to investigate the pharmacokinetic properties of fluralaner in Beagle dogs following single oral or intravenous i.v. administration. Methods: Following the oral administration of 12.5, 25 or 50 mg fluralaner-kg body weight BW, formulated as chewable tablets or i.v. administration of 12.5 mg fluralaner-kg BW, formulated as i.v. solution to 24 Beagles, plasma samples were collected until 112 days after treatment. Plasma concentrations of fluralaner were measured using HPLC-MS-MS. Pharmacokinetic parameters were calculated by non-compartmental methods. Results: After oral administration, maximum plasma concentrations Cmax were reached within 1 day on average. Fluralaner was quantifiable in plasma for up to 112 days after single oral and i.v. treatment. The apparent half-life of fluralaner was 12–15 days and the mean residence time was 15–20 days. The apparent volume of distribution of fluralaner was 3.1 L-kg, and clearance was 0.14 L-kg-day. Conclusions: Fluralaner is readily absorbed after single-dose oral administration, and has a long elimination half-life, long mean residence time, relatively high apparent volume of distribution, and low clearance. These pharmacokinetic characteristics help to explain the prolonged activity of fluralaner against fleas and ticks on dogs after a single oral dose.



Autor: Kilp, Susanne; Ramirez, Diana; Allan, Mark J; Roepke, Rainer KA; Nuernberger, Martin C

Fuente: https://archive.org/







Documentos relacionados